Market News & Analysis

Top Story

FTSE fares better than peers as UK gets ready to reopen

The Prime Minister is due to lay out plans to reopen UK work places at some point this week and documents leaked to the Sunday newspapers provided a glimpse into the blue print.  Staggered shifts, social distancing and plastic screens in shops and bank branches will be put in place so that businesses and retail outlets can open their doors again. Unlike its European peers the FTSE started the week on a slightly positive note, initially withstanding the tide of negative sentiment prompted by renewed tariff fears after President Trump intesified his attacks on China.

In London, Ppharma firms, waste disposal firm Rentokill Initial and delivery group Ocado are among the top gainers this morning, followed by gold miner Polymetal, a corona defence stock. Hikma Pharmaceuticals, a maker of non-branded generic medication, continued last week’s rally which was prompted by the company reporting revenue growth despite difficult market conditions. 

This week could see several heated boardroom discussions over chief executives’ bonus payments starting with Ocado where chief executive Tim Steiner expects to see a payout of £59m in the form of a long term bonus. GlaxoSmithKline and Barclays will also have board meetings this week.

BoE’s quarterly inflation report

This week’s Bank of England quarterly inflation report is bound to make uncomfortable reading, showing for the first time in detail how big an impact the last month and a half of the lockdown have had on the UK economy. The big question is, will the Bank be able to continue with the emergency bond purchases announced in March or will it start having to reduce its quantitative easing programme?


This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit for the complete Risk Disclosure Statement.

Important Notice:

Cryptocurrencies are not legal tender currency and trading of derivatives on Cryptocurrencies are currently not covered under any regulatory regime in Singapore. Consequently, investors should be aware they do not have protection under the Securities and Futures Act (Cap. 289). Please ensure that you are fully aware of the risks.